Zoltan Griger
Debrecen, HB, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Correction: Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub‑analysis of the ProDERM Study.
Journal: Rheumatology and therapy
Published: August 13, 2026
A Phase 3 Trial of Brepocitinib in Dermatomyositis.
Journal: The New England journal of medicine
Published: March 30, 2026
Clinical Relevance and Methodological Comparison of Anti-MDA5 Antibody Detection: A Five-Year Retrospective and Exploratory Pilot Study.
Journal: Biomolecules
Published: March 20, 2026
Management and Prognosis of Anti-MDA5 Dermatomyositis: Insights from a National Multicenter Cohort.
Journal: Biomedicines
Published: February 14, 2026
Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysis.
Journal: Seminars in arthritis and rheumatism
Published: July 31, 2025
Disease Activity-Dependent Siglec-1 Expression on Monocyte Subsets of Patients with Idiopathic Inflammatory Myopathies.
Journal: International journal of molecular sciences
Published: April 14, 2025
Assessment of Efficacy and Safety of Lipid-Lowering Treatment and Its Importance in Risk Assessment and Prevention in a Hungarian Myositis Cohort.
Journal: Journal of clinical medicine
Published: March 27, 2025
Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study.
Journal: Rheumatology and therapy
Published: March 21, 2025
Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study.
Journal: Rheumatology (Oxford, England)
Published: October 03, 2024
Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international network.
Journal: Seminars in arthritis and rheumatism
Published: April 20, 2024
Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies - A longitudinal study.
Journal: Seminars in arthritis and rheumatism
Published: September 23, 2023
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.
Journal: Arthritis research & therapy
Published: June 08, 2023
Last Updated: 09/26/2026